BioCentury
ARTICLE | Company News

AntiOp, Reckitt Benckiser deal

May 26, 2014 7:00 AM UTC

Reckitt's Reckitt Benckiser Pharmaceuticals Inc. subsidiary partnered with AntiOp to co-develop and commercialize AntiOp's naloxone nasal spray to aid in the reversal of opioid overdose. Reckitt also...